New gel shows promise for dark skin patches

NCT ID NCT06940895

Completed Symptom relief Sponsor: Narrows Institute for Biomedical Research Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This small study tested a gel containing sirolimus (0.2%) on 5 adults with acanthosis nigricans, a condition causing dark, thick skin patches. The goal was to see if the gel safely lightens the skin and improves texture over 12 weeks. Researchers measured changes in skin color and a scoring chart for severity.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: sirolimus 0.2% gel
What this could lead to: If it works, this could point toward a topical treatment to lighten and smooth skin affected by acanthosis nigricans.
What could go wrong: This is a very small, early-phase trial with only 5 participants, so results may not apply to everyone. The treatment may not work or could cause skin irritation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates